Cansartan-Mepha 4, Tabletten - 7 Tablette(n) Swissmedic Key 60929008 Registration Holder Mepha Pharma AG Name Cansartan-Mepha 4, Tabletten Date of registration 30.11.2010 Original/Generic Generic Introduction of Sequence 30.11.2010 ATC-Classification Candesartan (C09CA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.10. Show package size 7 Tablette(n) Index Therapeuticus (Swissmedic) 02.07.10. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 1.50 Limitation No Deductible 10 % Consumer price 10.85 Feedback FB Daily cost GTIN 7680609290083 Medication Code Synthetika Pharmacode 5429624 Disponibility
Composition candesartanum cilexetilum 4 mg, maydis amylum, lactosum monohydricum 133.8 mg, triethylis citras, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.48 mg, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Candesartanum Cilexetil 4 mg
BAG: Active Agent Dose Candesartanum Cilexetil 4 mg
Inactive agents Dose Carmellosum Natricum Conexum Hydroxypropylcellulosum Lactose Monohydrate 133.8 mg Magnesii Stearas Maydis Amylum Pro Compresso Triethylis Citras
Source Data was imported : 05.08.2020
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
